Executive Salary
avg.$151,408
Bachem
Life Science/Biotechnology
Bubendorf, Switzerland
Description
Bachem Holding AG is a publicly traded pharmaceutical company founded in 1971, headquartered in Bubendorf, Basel-Landschaft, Switzerland. Employing approximately 2,300 staff members, Bachem specializes in the biotech and life sciences industry, providing comprehensive products and services across the entire research and development process. The company's core offerings include peptides, APIs, and other specialty chemicals, primarily serving B2B clients across various industries. With a revenue of around $688 million, Bachem operates a 360-degree business model, supporting clients from initial discovery through to commercial-scale production. Its global presence includes key offices and facilities in Switzerland, with additional operations serving the international biotech and pharmaceutical markets. Bachem's focus is on innovation in peptide chemistry, supporting research and development efforts worldwide.
Experteer Insights
Experteer Briefing
Company Trajectory
Bachem Holding AG, founded in 1971 and headquartered in Bubendorf, Basel-Landschaft, Switzerland, has established itself as a pioneer in the life sciences industry. By introducing the merchant supplier model in peptide production, Bachem shifted the industry away from captive supply, with approximately 70% now relying on merchant-based solutions. Over the decades, the company has continually expanded its capabilities and customer base, marking key milestones through strategic pivots, subsidiary development, and global market expansion. Looking forward, Bachem aims to build on its long-standing expertise by advancing innovation in peptide and oligonucleotide manufacturing.
Financial Setup
Bachem is publicly traded and operates with a robust financial structure supported by a global workforce of approximately 2,200 employees. The company’s business model is focused on serving B2B customers, providing end-to-end products and services across all phases of the life science value chain—from research and development to commercial-scale production. Bachem’s financial trajectory reflects diversification and growth, underpinned by consistent strategic investments and a commitment to delivering value to its stakeholders while serving an international clientele.
Development & Outlook
Bachem specializes in developing and manufacturing peptides and oligonucleotides for pharmaceutical and biotechnology companies worldwide, offering solutions for research, clinical, and commercial applications. The company has secured more than 100 patents as of October 2023, underscoring its leadership in proprietary manufacturing processes. Bachem is advancing ambitious sustainability goals, such as reducing energy consumption and greenhouse gas emissions per employee and achieving climate neutrality by 2030. The company supports the United Nations Sustainable Development Goals and has received recognition for its sustainability practices, including a Platinum EcoVadis rating. Ongoing initiatives to enhance diversity, equity, and inclusion, alongside adherence to industry-relevant ISO standards, position Bachem for continued growth and leadership within the sector.
Vacancies
Scientist/Sr. Scientist R&D
Bachem
Torrance, CA - USA
Quality Assurance Technical Operations Specialist
Bachem
Vista, CA - USA
Associate Quality Assurance Manager/Quality Assurance Manager
Bachem
Vista, CA - USA
Procurement Project Manager, CAPEX Projects
Bachem
Vista, CA - USA
Pi Data Historian, Integration System Engineer
Bachem
Vista, CA - USA